The Effect Of Egg White On Control of Phosphorus in Dialysis Patients
Not Applicable
Recruiting
- Conditions
- phosphorus control in dialysis patients.
- Registration Number
- IRCT20190701044061N1
- Lead Sponsor
- Kerman University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 130
Inclusion Criteria
Patients who have been at least three months since the start of hemodialysis
Patients with high phosphorus levels 5.5 mg/dl
Exclusion Criteria
Egg allergy
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Phosphorus. Timepoint: before and after egg white diet in hemodialysis patients at the end of week 4 and 8. Method of measurement: blood level.
- Secondary Outcome Measures
Name Time Method Albumin. Timepoint: before and after receiving of egg white diet in hemodialysis patients at the end of week 4 and 8. Method of measurement: Blood level.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms does egg white utilize to control phosphorus in dialysis patients?
How does egg white compare to standard phosphate binders in managing serum phosphorus levels in ESRD patients?
Are there specific biomarkers that predict dialysis patients' response to egg white-based phosphorus control?
What adverse events are associated with egg white consumption in chronic kidney disease patients on dialysis?
What combination therapies with egg white show promise for phosphorus management in renal failure?